Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Myriocin

EU orphan designation number: EU/3/15/1449   
Active ingredient: Myriocin
Indication: Treatment of retinitis pigmentosa
Sponsor: Nanovector s.r.l.
Environment Park, Via Livorno 60, 10144 Torino, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/02/2015 Orphan designation EMA/OD/271/14 (2015)954 of 12/02/2015